Amazfit
Clinical-grade cardiac monitoring
Milpitas, CA, United States
Consumer smartwatch and wearable technology brand providing 24/7 health monitoring, fitness tracking, and AI-powered wellness insights, part of Zepp Health Corporation.
How We Help
Problem Statement
Amazfit aims to solve the problem of individuals lacking accessible, comprehensive tools to monitor and improve their overall wellness and fitness, providing technology to track key health metrics and offer personalized guidance.
Core Technology
AI-powered wellness insights
Key Differentiators
Long battery life of 10-21 days
Clinical Focus
General health and fitness monitoring, respiratory disease activity tracking, advanced hearing solutions.
Target Customers
Consumers (individuals focused on wellness and fitness)
Product Stage
Mature
Company Info
- Business Model
- B2C, Subscription
- Founded
- 2015
- Total Funding
- 25,000,000
- Website
- www.amazfit.com
Categories
Technologies
Clinical & IP
Clinical Validation
Stanford sleep study (clinical-grade accuracy). Peking University arrhythmia trial (94.76% ECG accuracy). Holter monitor equivalence study in elderly. Multiple peer-reviewed publications. Not FDA-cleared; operates in wellness category.
IP Protection
Proprietary technologies, including BioTracker™ sensor, Zepp OS, and AI chips (e.g., Huangshan-1 AI chip).
MedStartr Index Score
?What do you think of Amazfit?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.